Ceryvyn Therapeutics Ltd Financials
CKDXF
All currency values in A$ millions unless otherwise noted
Scroll
| Income Statement | JUN 2026 | JUN 2025 | JUN 2024 | JUN 2023 | JUN 2022 |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenue | A$0 | A$0 | A$0 | A$0 | A$0 |
| Cost of Revenue | – | – | – | A$0 | A$0 |
| Gross Profit | – | – | – | -A$0 | -A$0 |
| Total Operating Expenses | – | – | – | A$150 | A$96 |
| Operating Income | -A$12 | -A$236 | -A$192 | -A$150 | -A$97 |
| Non-Operating | |||||
| Net Interest Expense | -A$11 | -A$72 | -A$30 | -A$13 | A$0 |
| Income Tax Expense | -A$0 | -A$11 | -A$9 | -A$6 | -A$6 |
| Net Income | |||||
| Net Income | A$330 | -A$251 | -A$220 | -A$143 | -A$93 |
| Per Share Data | |||||
| Revenue Per Share | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 |
| EPS (Basic) | A$0.19 | -A$0.21 | -A$0.35 | -A$0.28 | -A$0.23 |
| EPS (Diluted) | A$0.19 | -A$0.21 | -A$0.35 | -A$0.28 | -A$0.23 |
| Shares Outstanding | 1.71B | 1.71B | 1.09B | 509.8M | 404.9M |
Ceryvyn Therapeutics (CKDXF) financials: revenue, profit and margins
Ceryvyn Therapeutics (CKDXF) generated about A$1,000.00 in revenue and A$330 million in net income (a 33,044,500.0% net margin) over the trailing twelve months, growing at roughly -67.6% a year. Figures are from company filings; this is analysis, not investment advice.
Frequently asked
What is Ceryvyn Therapeutics's (CKDXF) revenue?+
Ceryvyn Therapeutics generated about A$1,000.00 in revenue over the trailing twelve months. Revenue has grown at roughly -67.6% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.
Is Ceryvyn Therapeutics profitable?+
Yes, Ceryvyn Therapeutics reported about A$330 million in net income over the trailing twelve months, a net profit margin of roughly 33,044,500.0%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
What are Ceryvyn Therapeutics's profit margins?+
Ceryvyn Therapeutics runs an operating margin of about -1,194,700.0%, a net margin of about 33,044,500.0%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.
How fast is Ceryvyn Therapeutics growing?+
Ceryvyn Therapeutics's revenue has compounded at roughly -67.6% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside CKDXF's margins and free cash flow. This is analysis from company filings, not investment advice.
Peers
Biotechnology · Pick stocks to compare with CKDXF
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing CKDXF
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.